Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Image Competition 2023 Results, Part 1—Best Overall

Mary Purcell, MD  |  Issue: December 2023  |  December 8, 2023

For the 2023 Image Competition, the ACR sought images representing a diverse range of patients with idiopathic inflammatory myopathies (IIMs) or IIM mimics. The images selected as Best Overall by the judges this year come from North America.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Systemic Light Chain (AL) Amyloidosis Masquerading as Inflammatory Myositis

Click to enlarge.

These images depict an 81-year-old man who presented with a two-year history of progressive dysphagia, which was associated with weight loss and generalized weakness. He had periorbital hyperpigmentation (A) and prominent submandibular glands (B). His creatine kinase was elevated, and electromyography showed an irritable myopathy. Muscle biopsy demonstrated severe neurogenic atrophy without obvious myositis. Small and large perimysial and epimysial vessels showed glassy, pink thickening approaching nodularity in areas. The material was strongly positive for Congo red (C) and exhibited the characteristic birefringence of amyloid on polarization (D). Mass spectroscopy analysis demonstrated the amyloid material was light chain in origin.

Learn More

There are more than 30 amyloid precursor proteins, which, in healthy individuals, remain soluble. When proteins, such as the kappa or lambda light chain or transthyretin, become insoluble, they can cause amyloidosis. For more information on the condition, refer to articles in The Rheumatologist’s archives:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Amyloidosis Is Often Underdiagnosed, Undertreated; and
  • What Rheumatologists Need to Know about Identifying Amyloidosis.

Mary Purcell, MD, received her degree from Dalhousie University, Nova Scotia, Canada, where she also

completed her residency in rheumatology.

About the Contest

The Rheumatology Image Library is a highly accessed teaching resource and images from the ACR’s annual contest are added to it, keeping the library dynamic and current. In addition to the Best Overall Image in 2023, winning images were selected from four regions around the world. Look for the People’s Choice and regional winners in future issues and on our website.

Share: 

Filed under:ConditionsMyositisOther Rheumatic Conditions Tagged with:Amyloidosisimage case reportImage Competition

Related Articles

    What Rheumatologists Need to Know about Identifying Amyloidosis

    June 1, 2013

    Although amyloidosis is not a rheumatic disease, rheumatologists may be the first to diagnose this life-threatening condition

    The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease

    October 16, 2017

    An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….

    An Amylodosis Warning & New Drug Hope

    March 17, 2018

    SAN DIEGO—Treatments do exist that can improve the prospects of a patient with the rare disease amyloidosis, but only if clinicians keep the disease in mind and treat the patient before it’s too late, an expert said at the 2017 ACR/ARHP Annual Meeting this past November. He also discussed research that may be close to…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences